Cytokine Programme
Cytokine Programme
Introducing our new RIQAS Cytokine programme. The RIQAS Cytokine programme is a comprehensive EQA programme suitable for monitoring the performance of 12 different Cytokines.
- Lyophilised for enhanced stability
- Submit results and view reports online via RIQAS.Net
- All samples should be analysed and results submitted together
- Samples are manufactured to the highest quality ensuring the matrix reacts in same manner as patients sample.
- Cycle Starts October 2025
| Cat No | Kit Size | Parameters | Returns | |
|---|---|---|---|---|
| RQ9195 | 12 x 1ml | 12 | 1 sample per month | |
Parameters
• Epidermal Growth Factor (EGF)*
• Interleukin – 1 alpha (IL-1α)*
• Interleukin – 1 beta (IL-1β)*
• Interleukin – 2 (IL-2)*
• Interleukin – 4 (IL-4)*
• Interleukin – 6 (IL-6)
• Interleukin – 8 (IL-8)*
• Interleukin – 10 (IL-10)*
• Interferon gamma (INF-Y)*
• Monocyte Chemoattractant Protein -1 (MCP-1)*
• Tumour Necrosis Factor alpha (TNF-α)*
• Vascular Endothelial Growth Factor (VEGF)*
*Pilot parameters.
Please note, product availability may vary country to country.
Co-Oximetry EQA | RIQAS
The RIQAS CO-Oximetry EQA programme is a comprehensive programme suitable for monitoring the performance of 7 CO-Oximetry parameters. All samples are supplied in a lyophilised format, providing greater stability and ensuring clinically relevant levels.
- Lyophilised (January 2024)
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Cycle Starts – January 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9177 * | 6 x 1ml | Monthly (1 x 12 month cycle) | 7 | |
| RQ9177/A ** | 6 x 1ml | Monthly (1 x 12 month cycle) | 7 | |
Note to participants with multiple instruments on the CO-Oximetry Programme:
RQ9177 must be purchased for the first registered instrument and individual RQ9177/A kits purchased for each subsequently registered instrument.
Please note, product availability may vary country to country.
Parameters
- Carboxyhaemoglobin (COHb / HbCO)
- Methaemoglobin (MetHb)
- Oxygen Content (O₂CT)
- Oxygen Saturation (sO₂ / Vol O₂)
- Oxyhaemoglobin (O₂Hb / HbO₂)
- Total Haemoglobin (tHb)
- Reduced / Deoxyhaemoglobin (RHb / HHb)
About CO-Oximetry EQA
Co-oximetry is a methodology, also known as spectrophotometry, that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells. Co-oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin.
Spectrophotometric methods date back to studies by Sir Isaac Newton in the 1600s. Work by Lambert (1760) and Beer (1852) resulted in the Beer-Lambert law which describes the transmission / absorption of light in solutions (Chatburn, 2014).
A high value for the Co-Oximetry Blood Test may indicate, among other things:
- Carbon monoxide poisoning
- Congenital haemoglobin disorder
Related Products
Specific Protein External Quality Assessment
The RIQAS Specific Protein EQA programme is designed to monitor the performance of up to 26 serum proteins including CRP, ASO, RF, Complement Proteins and Immunoglobulins. Four programme options are available to help reduce waste and costs.
- Accredited to ISO/IEC 17043
- Liquid ready-to-use
- 100% human serum
- Flexible options available with bi-weekly or monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
Cycles Start:
RQ9114 (Bi-Weekly) – March/September 2025
RQ9187 (Monthly) – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9114 | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | 26 analytes | |
| RQ9187 | 12 x 1ml | Monthly (1 x 12 month cycle) | 26 analytes | |
Parameters
- AFP
- Albumin
- Alpha-1-acid glycoprotein
- Alpha-1-antitrypsin
- Alpha-2-macroglobulin
- Anti Streptolysin O
- Antithrombin III
- Beta-2-microglobulin
- Ceruloplasmin
- Complement, C3
- Complement, C4
- C-Reactive Protein
- Ferritin
- Haptoglobin
- Immunoglobulin A
- Immunoglobulin E
- Immunoglobulin G
- Immunoglobulin M
- Free Kappa Light Chain
- Total Kappa Light Chain
- Free Lambda Light Chain
- Total Lambda Light Chain
- Prealbumin (Transthyretin)
- Retinol Binding Protein
- Rheumatoid Factor
- Transferrin
Please note, product availability may vary country to country.
Related Products
Cardiac Plus External Quality Assessment
The RIQAS Cardiac Plus EQA programme is designed to monitor the performance of 11 clinically significant cardiac markers. All samples are supplied in a lyophilised format.
- Accredited to ISO/IEC 17043
- Lyophilised
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments at no extra cost
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9190 | 12 x 3ml | Monthly (1 x 12 month cycle) | 11 parameters | |
Parameters
- CK Total
- CK-MB Activity
- CK-MB Mass
- D-Dimer
- Digoxin
- Homocysteine
- hsCRP
- Myoglobin
- NT-proBNP
- Troponin I
- Troponin T
Please note, product availability may vary country to country.
Syphilis External Quality Assessment
The RIQAS Syphilis EQA programme is designed to monitor the performance of Syphilis tests using immunoassay, RPR, VDRL and TPHA based methods. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
- Liquid ready-to-use
- 100% human serum
- Monthly reporting (6 samples per bi-annual distribution)
- Submit results and view reports online via RIQAS.Net
- Suitable for both quantitative and qualitative methods of analysis
- Cycle Starts – July 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9154 | 6 x 1ml (1 sample to be tested per month. Samples shipped twice per year) | Monthly reporting (1 x 12 month cycle) | 1 | |
Parameters
- Syphilis
Please note, product availability may vary country to country.
Epstein Barr Virus External Quality Assessment
The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
- Liquid ready-to-use
- 100% human serum
- Monthly reporting (6 samples per bi-annual distribution)
- Submit results and view reports online via RIQAS.Net
- Suitable for both quantitative and qualitative methods of analysis
- Cycle Starts – July 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Analytes | |
|---|---|---|---|---|
| RQ9153 | 6 x 1ml (1 sample to be tested per month. Samples shipped twice per year) | Monthly reporting (1 x 12 month cycle) | 3 | |
Parameters
- Anti-EBNA IgG
- Anti-EBV VCA IgG
- Anti-EBV VCA IgM
Please note, product availability may vary country to country.
Immunoassay Speciality 2 External Quality Assessment
The RIQAS Immunoassay Speciality 2 EQA programme is designed to monitor the performance of 5 complex, specialised immunoassay parameters.
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Accredited to ISO/IEC 17043
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9142 | 12 x 1ml | Monthly Reporting (1 x 12 month cycle) | 5 | |
Parameters
- Calcitonin
- Gastrin
- Procalcitonin
- Plasma Renin Activity
- Renin, direct concentration
Please note, product availability may vary country to country.
Related Products
Human Urine External Quality Assessment
The RIQAS Human Urine EQA programme is designed to monitor the performance of 25 routine chemistry assays in urine.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human urine
- Flexible options available with bi-weekly or monthly reporting
- 10ml samples provided
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
Cycles Start:
RQ9115 (Bi-Weekly) – January 2025
RQ9185 (Monthly) – July 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9115 | 24 x 10ml | Bi-Weekly (2 x 6 month cycles) | 25 | |
| RQ9185 | 12 x 10ml | Monthly (1 x 12 month cycle) | 25 | |
Parameters
- Albumin / Microalbumin
- Albumin/Creatinine Ration
- Amylase
- Calcium
- Chloride
- Copper
- Cortisol
- Creatinine
- Dopamine
- Epinephrine
- Glucose
- Magnesium
- Metanephrine
- Norepinephrine
- Normetanephrine
- Osmolality
- Oxalate
- Phosphate, inorganic
- Potassium
- Protein, total
- Sodium
- Urea
- Uric acid
- VMA
- 5-HIAA
Please note, product availability may vary country to country.
Related Products
Cardiac External Quality Assessment
The RIQAS Cardiac EQA programme is designed to monitor the performance of up to 7 clinically significant cardiac markers. Three flexible reporting options are available to suit the needs of all laboratory sizes.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Flexible options available with bi-weekly or monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments at no extra cost
Cycles Start:
RQ9127 – March/September 2025
RQ9186 – March 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9127/A | 12 x 1ml | Bi-weekly (2 x 6 monthly cycles) | 2 (Choose from 7) | |
| RQ9127/B | 12 x 1ml | Bi-weekly (2 x 6 monthly cycles) | 7 | |
| RQ9186 | 12 x 1 ml | Monthly | All 7 parameters (monthly reporting) | |
Parameters
- CK, Total
- CK-MB activity units
- CK-MB mass units
- Homocysteine
- Myoglobin
- Troponin I
- Troponin T
Please note, product availability may vary country to country.
Related Products
BNP External Quality Assessment
The RIQAS BNP programme is a dedicated programme suitable for monitoring the performance of B-type Natriuretic Peptide. All samples are supplied in a liquid ready-to-use format, therefore reducing the amount of preparation time required and reducing the risk of human error.
- Liquid ready-to-use
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Cycle Starts – January 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9165 | 12 x 1ml | Monthly | 1 | |
Order with RQ9136/a when BNP and Liquid Cardiac parameters required
Parameters
- BNP
Please note, product availability may vary country to country.